<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Segoe UI";
panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72">
<div class="WordSection1">
<p class="MsoNormal"><b><img width="960" height="343" style="width:10.0in;height:3.5729in" id="_x0000_i1025" src="cid:image001.jpg@01D740CC.CE735550"><o:p></o:p></b></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">Medicine and laboratory testing are constantly changing. In an attempt to keep us all on the same page, the Laboratory Formulary Committee will be regularly sending out emails
with recent updates and guidances. Below are the short versions of relevant changes. Attached are more in-depth resources about the changes.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">Sickle Cell and other hemoglobinopathy testing:
</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif;font-weight:normal">Quantitative testing for different hemoglobins is crucial in patients with Sickle Cell disease and other hemoglobinopathies. This testing is now being
performed using a new methodology. Two tests are available: “</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">Hemoglobinopathy/Thalassemia Evaluation”</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif;font-weight:normal">(Epic
code </span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">LAB2732</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif;font-weight:normal">) should be used for initial diagnostic testing
and “</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">Hemoglobin S/A/F Monitoring”
</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif;font-weight:normal">(Epic code
</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">LAB3500</span></strong><strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif;font-weight:normal">) should be used for on-going monitoring of known sickle
cell disease patients. </span></strong><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">Please see the attached guidance for details.
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Segoe UI",sans-serif">For prior guidances, please visit
<a href="https://urldefense.com/v3/__https:/upstate0.sharepoint.com/sites/LaboratoryFormularyCommitteeLabchanges__;!!GobTDDpD7A!fMqwKEI3JlieL_eF-Vo4vMVj2PNzfXcL0GsxYMLCbL6cXpbRqzmyQKWIxbV1BBgJ8OlmOsFv$">
https://upstate0.sharepoint.com/sites/LaboratoryFormularyCommitteeLabchanges</a><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>